Box Office Autopsy: The 10 Biggest Bombs of 2016 (so far)

As much as it may be lamented, film-making is a business, and the goal of studios is to make money. Every so often (perhaps increasingly often) movies fail in that goal during their theatrical runs, and are dubbed bombs. They could make that money back on home media, but the earnings from these revenue streams are far less advertised. Much like my last Box Office Autopsy post, I haven’t taken into account marketing costs, since they are not widely available. To come up with profit numbers, I divided worldwide grosses by two and subtracted the production budget.

There are two ways to judge which movies are the biggest bombs of 2016: absolute loss of capital, and failure to return on investment. Rather than cop out and make two lists, I decided to unscientifically average the two numbers to make one master list. Without further ado, the 10 biggest bombs of 2016 (so far). (Zoolander 2 is #11)

Continue reading “Box Office Autopsy: The 10 Biggest Bombs of 2016 (so far)”